MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patientsMathilde Saint‐Ghislain, Manuel Rodrigues, Thierry Lesimple et al.|European Journal of Cancer|2022Cited by 37
<i>MBD4</i> deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients: A retrospective study.Mathilde Saint‐Ghislain, Manuel Rodrigues, Lionnel Geoffrois et al.|Journal of Clinical Oncology|2022Cited by 2